CE Certified Viral Nucleic Acid Manufacturers - Reliable Quality for Your Needs

At Shanghai Gene Era Bio-Science Co., Ltd., we understand the vital role that high-quality viral nucleic acids play in your projects. Our advanced manufacturing facility is dedicated to producing a comprehensive range of viral nucleic acids, ensuring that each batch meets the highest standards of consistency and purity. Our focus on rigorous testing and stringent quality control reflects our commitment to excellence. With years of experience in the field, we are equipped to provide customized solutions that cater to your specific requirements, making us a dependable partner for your research and development needs.

Hot Selling Product

Viral preservation fluids

GEB High Quality Robotic Tips 1000μL For Olimpus

GEB High Quality Robotic Tips 2500μL For Hitachi

CP DNA gel recovery kit

Sample Preservation Medium

Leading Chinese Viral Nucleic Acid Leads the Global Market Service Backed by Expertise

In today's rapidly evolving world of molecular diagnostics, the demand for reliable and efficient testing solutions is greater than ever. As global procurement specialists seek high-quality products that can deliver accurate results, the importance of expertise in the development and application of nucleic acid testing becomes paramount. Leading the charge in this domain is a company recognized for its comprehensive end-to-end solutions that streamline the diagnostics process from sample preparation through to precise testing. With applications spanning agriculture, pet healthcare, and public health, the versatility of these diagnostic tools is a game-changer in various industries. For agriculture, early detection of pathogens can significantly improve crop yields and reduce losses, while in pet healthcare, accurate diagnostics ensure the prompt treatment of animals, improving their health outcomes. Public health benefits enormously from sophisticated testing technologies that facilitate swift responses to emerging health threats, thereby safeguarding communities. As global buyers seek trusted partners in the molecular diagnostics space, collaborating with an organization that combines technical expertise with a commitment to innovation can drive significant advancements. By leveraging cutting-edge technology and scientific research, this industry leader is well-positioned to meet the diverse needs of customers around the world, ensuring they have access to superior diagnostic solutions that keep pace with the dynamic challenges of today's health landscape.

Leading Chinese Viral Nucleic Acid Leads the Global Market Service Backed by Expertise

Market Segment	Market Size (USD Billion)	Growth Rate (%)	Regional Share (%)	Key Technologies
Infectious Diseases	25.4	7.5	35	RT-PCR, NGS
Oncology	18.2	8.2	25	Microarray, NGS
Genetic Testing	15.6	9.1	20	Sanger Sequencing, PCR
Prenatal Testing	10.3	6.3	15	Non-invasive Prenatal Testing
Veterinary Diagnostics	5.4	5.6	5	PCR, ELISA

Global Market Share of Nucleic Acid Testing Technologies (2020-2023)

The chart illustrates the global market share of nucleic acid testing technologies from 2020 to 2023. The data shows a consistent growth in market share, highlighting the increasing adoption and reliance on nucleic acid testing in various sectors, including healthcare and diagnostics. In 2020, the market share was approximately 45%, which rose to 50% in 2021, reflecting an early recognition of the technology’s potential, particularly during the COVID-19 pandemic. The growth trajectory continued in 2022 when the market share reached 60%, driven by advancements in testing speed and accuracy. By 2023, the market share is projected to hit 70%, demonstrating a strong global trend towards integrating nucleic acid testing solutions into routine health assessments and epidemic response strategies. This upward movement showcases the expertise backing these technologies and their capacity to address emerging health challenges worldwide.